オンコセラピー・サイエンス(株)の日証金速報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証GRT | 医薬品 | 4564/E05363 | OncoTherapy Science,Inc. |
計算日 | 公表 | 買残 | 新規/返済 | 売残 | 新規/返済 | 倍率 |
---|---|---|---|---|---|---|
2020/09/30 | 日証金 | 3,400,000株 +419,600 | 782,500 362,900 | 2,867,000株 -113,400 | 86,600 200,000 | 1.19倍 |
2020/09/29 | 日証金 | 2,980,400株 -3,500 | 147,600 151,100 | 2,980,400株 -3,500 | 0 3,500 | 1倍 |
2020/09/28 | 日証金 | 2,983,900株 +144,000 | 1,087,000 943,000 | 2,983,900株 +144,000 | 150,000 6,000 | 1倍 |
2020/09/25 | 日証金 | 2,839,900株 -293,000 | 1,424,500 1,717,500 | 2,839,900株 +314,800 | 355,000 40,200 | 1倍 |
2020/09/24 | 日証金 | 3,132,900株 +652,500 | 970,200 317,700 | 2,525,100株 +44,700 | 44,700 0 | 1.24倍 |
2020/09/23 | 日証金 | 2,480,400株 0 | 359,300 359,300 | 2,480,400株 0 | 0 0 | 1倍 |
2020/09/18 | 日証金 | 2,480,400株 -63,200 | 298,500 361,700 | 2,480,400株 0 | 0 0 | 1倍 |
2020/09/17 | 日証金 | 2,543,600株 +63,200 | 253,900 190,700 | 2,480,400株 0 | 0 0 | 1.03倍 |
2020/09/16 | 日証金 | 2,480,400株 0 | 731,600 731,600 | 2,480,400株 0 | 0 0 | 1倍 |
2020/09/15 | 日証金 | 2,480,400株 -480,700 | 865,000 1,345,700 | 2,480,400株 0 | 0 0 | 1倍 |
2020/09/14 | 日証金 | 2,961,100株 +73,400 | 140,800 67,400 | 2,480,400株 0 | 0 0 | 1.19倍 |
2020/09/11 | 日証金 | 2,887,700株 -28,800 | 52,900 81,700 | 2,480,400株 0 | 0 0 | 1.16倍 |
2020/09/10 | 日証金 | 2,916,500株 +61,400 | 85,200 23,800 | 2,480,400株 0 | 0 0 | 1.18倍 |
2020/09/09 | 日証金 | 2,855,100株 +374,700 | 943,100 568,400 | 2,480,400株 0 | 0 0 | 1.15倍 |
2020/09/08 | 日証金 | 2,480,400株 -473,900 | 555,400 1,029,300 | 2,480,400株 0 | 0 0 | 1倍 |
2020/09/07 | 日証金 | 2,954,300株 +282,200 | 287,800 5,600 | 2,480,400株 0 | 0 0 | 1.19倍 |
2020/09/04 | 日証金 | 2,672,100株 +69,100 | 91,900 22,800 | 2,480,400株 0 | 0 0 | 1.08倍 |
2020/09/03 | 日証金 | 2,603,000株 +25,500 | 37,300 11,800 | 2,480,400株 0 | 0 0 | 1.05倍 |
2020/09/02 | 日証金 | 2,577,500株 +16,700 | 130,700 114,000 | 2,480,400株 0 | 0 0 | 1.04倍 |
2020/09/01 | 日証金 | 2,560,800株 +80,400 | 343,600 263,200 | 2,480,400株 0 | 0 0 | 1.03倍 |
2020/08/31 | 日証金 | 2,480,400株 -6,700 | 154,800 161,500 | 2,480,400株 0 | 0 0 | 1倍 |
※株式分割は考慮していませんのでご注意ください。